Thus, NT-3 was significantly elevated in breast cancer survivors (16.62 [11.18; 20.0] pg/mL) relative to the volunteer group (5.74 [4.56; 13.7] pg/mL) with p < 0.001. The gene discussed is NTF3; the disease is breast carcinoma.